Deep knowledge on
small-molecule drugs and
the 100,000 global patents
covering them

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: QNASL

« Back to Dashboard
Qnasl is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has forty-seven patent family members in seventeen countries.

The generic ingredient in QNASL is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for Tradename: QNASL

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list7

Pharmacology for Tradename: QNASL

Clinical Trials for: QNASL

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth
Status: Recruiting Condition: Asthma

The Effect of HFA - Beclomethasone Dipropionate Qvar on Bronchial Hyperreactivity in Preschool Children
Status: Completed Condition: Asthma; Bronchial Hyperresponsiveness

Effects of QVAR in Smokers With Asthma
Status: Recruiting Condition: Asthma

A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps
Status: Recruiting Condition: Nasal Polyps

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Status: Recruiting Condition: Asthma; Allergic Rhinitis

Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
Status: Completed Condition: Asthma

Qvar vs FP in Pediatrics
Status: Completed Condition: Asthma

Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis
Status: Completed Condition: Bronchial Spasm; Respiratory Sounds; Respiratory Tract Infections

Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD
Status: Completed Condition: Chronic Obstructive Pulmonary Disease

Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
Status: Completed Condition: Asthma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-002Dec 17, 2014RXNo5,776,432<disabled>Y <disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 2012RXYes5,776,432<disabled>Y <disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-002Dec 17, 2014RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: QNASL

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-002Dec 17, 20145,776,432<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 20125,776,432<disabled>
Teva Branded Pharm
QNASL
beclomethasone dipropionate
AEROSOL, METERED;NASAL202813-001Mar 23, 20125,605,674<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: QNASL

Country Document Number Publication Date
European Patent Office0499344Oct 11, 1995
Israel92457Oct 21, 1994
Israel92457Aug 31, 1990
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc